37.20 +0.00 (0.00%)
PRX
| Trade PRX now with |
|
Stock Details
Last Trade:37.20 Change:+0.00 (0.00%) Prev Close:37.20 Open: 37.07 Days Range:36.58 – 37.38 52 Week Range: 24.85 - 38.85 Volume:200942 P/E: N/AEPS:-1.74
View AllRecent Alerts 02/09/12
Recent Alert on 01/09/12 at 10:51am
UBS Maintains a 'Buy' on Par Pharmaceutical (PRX); Shaping Up To Be Strong Growth Story
UBS Maintains a 'Buy' on Par Pharmaceutical (PRX); Shaping Up To Be Strong Growth Story
UBS maintains a 'Buy' on Par Pharmaceutical (NYSE: PRX) price target raised from $39 to $42. UBS analyst says, "Our takeaway: Better-than-expected EPS growth guidance; Raising numbers - Management gave an impressive 15% 2012-2014 cash EPS growth... Read More
Recent Alert on 01/09/12 at 8:24am
Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Analyst Day Highlights Strong Generic Fundamentals, Enhanced Capability and Capacity
Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Analyst Day Highlights Strong Generic Fundamentals, Enhanced Capability and Capacity
Recent Alert on 01/06/12 at 11:20am
Needham & Company: Thoughts Heading Into Par Pharmaceutical's (PRX) January 6, Analyst Day; Generics Take Center Stage
Needham & Company: Thoughts Heading Into Par Pharmaceutical's (PRX) January 6, Analyst Day; Generics Take Center Stage
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 01/26/12 at 6:44am
54 'Safe' Stocks From Greenblatt's Magic Formula And Altman's Z-Score
54 'Safe' Stocks From Greenblatt's Magic Formula And Altman's Z-Score
Blog Posts on 11/01/11 at 10:42am
Intellipharmaceutics Reaches Key Milestone As Analysts Raise Price Targets Ahead Of Another One
Intellipharmaceutics Reaches Key Milestone As Analysts Raise Price Targets Ahead Of Another One